CHANGES IN PHARMACOLOGICAL TREATMENT PATTERN FOR TYPE 2 DIABETES IN FIVE YEARS: BEFORE AND AFTER THE INTRODUCTION OF DIPEPTIDYL PEPTIDASE-4 (DPP-4) INHIBITOR AT A DIABETES SPECIALIST CLINIC IN TOKYO

被引：0
|
作者：
Watanabe, Y. [1 ]
Takayama, C. [2 ]
Asada, Y. [2 ]
Mori, T. [2 ]
Kawagoe, Y. [1 ]
Fujii, H. [1 ]
Miyakawa, T. [1 ]
机构：
[1] Tama Ctr Mirai Clin, Internal Med, Tokyo, Japan
[2] Yamato Prescript Ctr, Tokyo, Japan
来源：
DIABETES RESEARCH AND CLINICAL PRACTICE | 2014年 / 106卷
关键词：
D O I：
10.1016/S0168-8227(14)70492-9
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PO198
引用
收藏
页码：S148 / S149
页数：2
相关论文
共 50 条
  • [21] Dipeptidyl Peptidase-4 (Dpp-4) Inhibitor (Sitagliptin) as a Novel Treatment Agent for Nonalcoholic Fatty Liver Disease Patients With Type 2 Diabetes Mellitus
    Tomeno, Wataru
    Yoneda, Masato
    Imajo, Kento
    Mawatari, Hironori
    Kirikoshi, Hiroyuki
    Saito, Satoru
    Shibata, Wataru
    Yoneda, Kyoko
    Endo, Hiroki
    Kubota, Kensuke
    Nakajima, Atsushi
    GASTROENTEROLOGY, 2012, 142 (05) : S1017 - S1017
  • [22] Acute pancreatitis with dipeptidyl peptidase-4 (DPP4) inhibitor or fulminant type 1 diabetes?
    Amouyal, C.
    Levy, P.
    Andreelli, F.
    Hartemann, A.
    DIABETES & METABOLISM, 2018, 44 (01) : 95 - 96
  • [23] A dipeptidyl peptidase-4 (DPP-4) inhibitor, linagliptin, attenuates cardiac dysfunction after myocardial infarction independently of DPP-4
    Yamaguchi, Takehiro
    Watanabe, Ayano
    Tanaka, Masako
    Shiota, Masayuki
    Osada-Oka, Mayuko
    Sano, Soichi
    Yoshiyama, Minoru
    Miura, Katsuyuki
    Kitajima, Shojiro
    Matsunaga, Shinji
    Tomita, Shuhei
    Iwao, Hiroshi
    Izumi, Yasukatsu
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2019, 139 (02) : 112 - 119
  • [24] Saxagliptin A New Dipeptidyl Peptidase-4 Inhibitor for Type 2 Diabetes
    Lam, Sum
    Saad, Maha
    CARDIOLOGY IN REVIEW, 2010, 18 (04) : 213 - 217
  • [25] Acute onset of rheumatoid arthritis associated with administration of a dipeptidyl peptidase-4 (DPP-4) inhibitor to patients with diabetes mellitus
    Sasaki T.
    Hiki Y.
    Nagumo S.
    Ikeda R.
    Kimura H.
    Yamashiro K.
    Gojo A.
    Saito T.
    Tomita Y.
    Utsunomiya K.
    Diabetology International, 2010, 1 (2) : 90 - 92
  • [26] Efficacy of different dipeptidyl peptidase-4 (DPP-4) inhibitors on metabolic parameters in patients with type 2 diabetes undergoing dialysis
    Park, Se Hee
    Nam, Joo Young
    Han, Eugene
    Lee, Yong-ho
    Lee, Byung-Wan
    Kim, Beom Seok
    Cha, Bong-Soo
    Kim, Chul Sik
    Kang, Eun Seok
    MEDICINE, 2016, 95 (32)
  • [27] Fragment-Based Drug Design to Discover Novel Inhibitor of Dipeptidyl Peptidase-4 (DPP-4) as a Potential Drug for Type 2 Diabetes Therapy
    Ningsih, Eka Gunarti
    Hidayat, Muhammad Fauzi
    Tambunan, Usman Sumo Friend
    BIOINFORMATICS AND BIOMEDICAL ENGINEERING, IWBBIO 2019, PT I, 2019, 11465 : 14 - 24
  • [28] Candidate Dipeptidyl Peptidase-4 Inhibitors for the Treatment of Type 2 Diabetes
    Jang, Yun-Mi
    Kim, Dong-Lim
    DIABETES & METABOLISM JOURNAL, 2011, 35 (02) : 117 - 118
  • [29] Finding a Potential Dipeptidyl Peptidase-4 (DPP-4) Inhibitor for Type-2 Diabetes Treatment Based on Molecular Docking, Pharmacophore Generation, and Molecular Dynamics Simulation
    Meduru, Harika
    Wang, Yeng-Tseng
    Tsai, Jeffrey J. P.
    Chen, Yu-Ching
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2016, 17 (06):
  • [30] Dipeptidyl Peptidase-4 Inhibitors for the Treatment of Type 2 Diabetes Mellitus
    Neumiller, Joshua J.
    Wood, Lindy
    Campbell, R. Keith
    PHARMACOTHERAPY, 2010, 30 (05): : 463 - 484
12345